Lower social class linked to increased risk of postoperative MRSA infection

February 26, 2004

Results of a UK study in this week's issue of The Lancet suggest that people from the poorest socioeconomic backgrounds could be up to seven times more likely to get postoperative infection with meticillin-resistant Staphylococcus aureus (MRSA) than people from affluent social groups. This heightened risk is more likely to be a result of increased hospital visits rather than due to community-based MRSA infection.

A link between social status and postoperative outcomes has not previously been reported. Jens Peder Bagger from Hammersmith Hospital and Imperial College, London, UK, categorised over 1700 patients undergoing coronary artery bypass grafting into socioeconomic groups based on patients' postcodes. 23 patients (1.3%) developed MRSA infection after surgery (not an unexpected proportion of infection). Patients from the most deprived areas had a seven-fold higher infection rate (13 of 579 [2.2%] ) than those from the least deprived areas (two of 580) [0.3%].

Patients with MRSA infection had a six-fold higher death rate and a longer hospital stay than patients with no MRSA infection.

Dr Bagger comments: "About half of our patients (12 of 23) with postoperative MRSA had been transferred from another hospital or department or had been admitted to hospital in the preceding 6 months. The resistance pattern suggests that the MRSA strains are more likely to be associated with hospitals than to originate from the community." He concludes that the study has identified "a target group for further monitoring and intervention to reduce this serious postoperative complication."
-end-
Contact: Dr Jens Peder Bagger, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK;
T) 44-208-383-3171;
F) 44-208-740-8373;
E) p.bagger@ic.ac.uk

Lancet

Related MRSA Articles from Brightsurf:

Widely available antibiotics could be used in the treatment of 'superbug' MRSA
Some MRSA infections could be tackled using widely-available antibiotics, suggests new research from an international collaboration led by scientists at the University of Cambridge and the Wellcome Sanger Institute.

Computer model shows how to better control MRSA outbreaks
A research team led by scientists at the Columbia University Mailman School of Public Health report on a new method to help health officials control outbreaks of methicillin-resistant Staphylococcus aureus, or MRSA, a life-threatening antibiotic-resistant infection often seen in hospitals.

Using MRSA's strength against it
MRSA evolved to become a deadly killer because it's wily and resilient.

Livestock-associated MRSAfound among MRSA from humans
The survey results show more frequent detections and geographical dispersion of LA-MRSA in humans in the EU/EEA since 2007, and highlight the public health and veterinary importance of LA-MRSA as a 'One Health' issue.

Fighting MRSA with new membrane-busting compounds
Public health officials are increasingly concerned over methicillin-resistant Staphylococcus aureus (MRSA).

Know thy enemy: Kill MRSA with tailored chemistry
UConn medicinal chemists have developed experimental antibiotics that kill MRSA, a common and often deadly bacteria that causes skin, lung, and heart infections.

MRSA uses decoys to evade a last-resort antibiotic
The superbug MRSA uses decoys to evade a last-resort antibiotic, reveals new research.

Scientists find a salty way to kill MRSA
Scientists have discovered a new way to attack Staphylococcus aureus bacteria.

Experimental antibiotic treats deadly MRSA infection
A new experimental antibiotic developed by a team of scientists at Rutgers University successfully treats the deadly MRSA infection and restores the efficacy of a commonly prescribed antibiotic that has become ineffective against MRSA.

OU team develops new antibiotic to fight MRSA
A University of Oklahoma team of chemists has developed a new antibiotic formulation to fight the sometimes deadly staph infection caused by methicillin-resistant S. aureus or MRSA and other antibiotic-resistant infectious bacteria.

Read More: MRSA News and MRSA Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.